1st Counsel – Lifestyle
Author:
AMGEN
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 28, 2026
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE
March 5, 2026
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND
March 4, 2026